Skip to content
Clinical Trials for Alzheimer's Disease

Boston, Massachusetts

Alzheimer's disease clinical trials in Boston, MA

27 Alzheimer's disease studies are recruiting participants at sites in Boston as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Boston at a glance

  • 27 studies are recruiting at a site in Boston.
  • By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (2), Phase 2 (5), Phase 3 (4), No phase (8), Observational (6). Studies of devices and behavioral approaches have no phase.
  • By sponsor: university, hospital or other (18), industry (7), government (2).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in Boston

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)

    • Observational
    • Ages 30 to 90
    • All sexes
    Sponsor
    VA Office of Research and Development
    Study site
    VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
    Registry record
    NCT04124029 · updated
  2. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Adams Clinical Boston
    Registry record
    NCT07177352 · updated
  3. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Adams Clinical Boston
    Registry record
    NCT07717411 · updated
  4. A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Intra-Cellular Therapies, Inc.
    Study site
    Tufts University School of Medicine
    Registry record
    NCT06651567 · updated
  5. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Tufts Medical Center - 800 Washington St - PPDS
    Registry record
    NCT06585787 · updated
  6. Alzheimer's Tau Platform: Master Protocol

    • Phase 2
    • Ages 50 to 80
    • All sexes
    Sponsor
    Paul S. Aisen
    Study site
    Brigham and Women's Hospital Center for Alzheimer Research and Treatment
    Registry record
    NCT06957418 · updated
  7. Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

    • Phase 2
    • Ages 55 and older
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT07236190 · updated
  8. Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

    • Phase 2
    • Ages 55 to 80
    • All sexes
    Sponsor
    Lighthouse Pharmaceuticals, Inc.
    Study site
    Adams Clinical Boston
    Registry record
    NCT06847321 · updated
  9. Dominantly Inherited Alzheimer Network (DIAN)

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    Washington University School of Medicine
    Study site
    Brigham and Women's Hospital
    Registry record
    NCT00869817 · updated
  10. Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation

    • No phase
    • Ages 50 to 100
    • All sexes
    Sponsor
    Boston University Charles River Campus
    Study site
    111 Cummington Mall. Room 264
    Registry record
    NCT06094192 · updated
  11. Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)

    • Observational
    • Ages 18 to 120
    • All sexes
    Sponsor
    University of Pennsylvania
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05658913 · updated
  12. Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease

    • No phase
    • Ages 50 to 90
    • All sexes
    Sponsor
    Boston University Charles River Campus
    Study site
    Boston University Neuromotor Recovery Laboratory
    Registry record
    NCT07659964 · updated
  13. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Eidos Therapeutics, a BridgeBio company
    Study sites
    Boston University (BU) School of Medicine · Brigham and Women's Hospital · Massachusetts General Hospital
    Registry record
    NCT06563895 · updated
  14. Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease

    • No phase
    • Ages 55 to 90
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05776641 · updated
  15. Trial-Ready Cohort-Down Syndrome (TRC-DS)

    • Observational
    • Ages 25 to 55
    • All sexes
    Sponsor
    University of Southern California
    Study site
    Massachusetts General Hospital, Co-Enrolling through ABC-DS Only
    Registry record
    NCT04165109 · updated
  16. Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease

    • Early Phase 1
    • Ages 40 to 99
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT06538311 · updated
  17. Cognitive Neurology Unit Clinical Registry

    • Observational
    • Ages 50 to 95
    • All sexes
    Sponsor
    Beth Israel Deaconess Medical Center
    Study site
    Beth Israel Deaconess Medical Center
    Registry record
    NCT05925621 · updated
  18. Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD

    • Observational
    • Ages 18 to 100
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05881239 · updated
  19. TMS for Cognitive Decline in Aging and Preclinical AD

    • No phase
    • Ages 40 to 99
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT06956300 · updated
  20. Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

    • Phase 2
    • Ages 60 to 85
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Study site
    Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
    Registry record
    NCT06489548 · updated
  21. PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases

    • Phase 1/2
    • Ages 18 to 85
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Study site
    Brigham MS Center, 60 Fenwood Road
    Registry record
    NCT02649985 · updated
  22. Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

    • No phase
    • Ages 55 and older
    • All sexes
    Sponsor
    Hebrew SeniorLife
    Study site
    Hinda and Arthur Marcus Institute for Aging Research
    Registry record
    NCT05661084 · updated
  23. Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

    • No phase
    • Ages 60 to 106
    • All sexes
    Sponsor
    Hebrew SeniorLife
    Study site
    Hebrew SeniorLife
    Registry record
    NCT05950607 · updated
  24. Assess Fibrin in Brains With AD/ADRD

    • Phase 1/2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Massachusetts General Hospital
    Study site
    Massachusetts General Hospital
    Registry record
    NCT05336695 · updated
  25. Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation

    • Phase 1
    • Ages 55 to 75
    • All sexes
    Sponsor
    General Biophysics LLC
    Study site
    Brigham and Women's Hospital
    Registry record
    NCT06945614 · updated
  26. Mindfulness for Cognition in Early-stage Alzheimer's Disease

    • No phase
    • Ages 50 to 100
    • All sexes
    Sponsor
    VA Boston Healthcare System
    Study site
    VA Boston Healthcare System - Jamaica Plain Campus
    Registry record
    NCT06792877 · updated
  27. Gamma-Music Based Intervention for Mild Alzheimer's Disease

    • No phase
    • Ages 50 to 95
    • All sexes
    Sponsor
    Northeastern University
    Study site
    Northeastern University
    Registry record
    NCT05984524 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Boston, MA on ClinicalTrials.gov.

Ask about studies near Boston

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Massachusetts

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call